薬物スクリーニングの市場規模、シェア、動向分析レポート：製品タイプ別、サンプルタイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

薬物スクリーニング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の薬物スクリーニング市場規模は2030年までに119億9,000万米ドルに達すると推定され、2025年から2030年にかけてCAGR 4.1％で拡大すると予測されています。

この市場を牽引しているのは、職場の安全に対する懸念の高まり、規制への対応、検査方法の技術的進歩に後押しされた薬物乱用の正確な検出要件です。

イングランドで薬物・アルコールサービスに接触している成人の数は、2020年～2021年の27万5,896人から2021年～2022年には28万9,215人へと4.8％増加しており、これは同国における薬物乱用の蔓延が拡大していることを示しています。薬物乱用の有病率の上昇は、エビデンスに基づく治療オプションへのアクセス拡大や、薬物・アルコール乱用のリスクに関する認識を高める公衆衛生キャンペーンなど、効果的な予防・治療戦略の必要性をさらに後押ししています。

さらに、2020年の12歳以上の米国人における違法薬物使用の発生率は約3,731万人であり、この数年間で前年比3.8%の増加を示しています。この増加は、職場、学校、ヘルスケア環境における包括的な薬物スクリーニングプログラムの緊急の必要性を浮き彫りにし、安全性、規制の遵守、薬物乱用に悩む人々への適切なケアとサポートの提供を確実にします。

さらに、新製品の発売、合併、買収などの市場プレイヤーのイニシアチブが市場成長に寄与しています。例えば、2024年2月、ニューヨークの大手薬物検査プロバイダーであるMobile Health社は、雇用者向けに迅速な薬物検査を開始し、1時間以内に結果が出るようにしました。精度と汎用性のために尿ベースの検査に焦点を当てたこの技術革新は、雇用手続きを進め、ニューヨークの人材獲得に革命をもたらしました。さらに、2023年12月には、遺伝子マーカーを通じて個人のオピオイド使用障害発症リスクを評価するAvertD検査がFDAに承認され、オピオイド危機との闘いにおける重要な技術革新となります。AutoGenomics社が開発したこの検査は、患者が初めて経口オピオイド鎮痛薬にさらされる前、特に外科手術を予定している患者に使用するよう設計されています。この検査は、患者やヘルスケアプロバイダーがオピオイドの使用について十分な情報を得た上で意思決定を行い、中毒や誤用のリスクを低減できる可能性があることを目的としています。

薬物スクリーニング市場レポートハイライト

• 消耗品は2024年に34.5%の最大売上シェアを占めたが、これは迅速、正確かつ現場での検査に不可欠な役割を果たすためです。さらに、製品の頻繁な発売や、職場やヘルスケア環境における効率的な物質検出の必要性も、この分野の成長を後押ししています。
• サービスその他は、予測期間中にCAGR 4.1％で成長すると予測されます。これは、検査室分析や規制基準遵守のサポートなど、専門的な薬物スクリーニングサービスのニーズが高まっているためです。
• 尿サンプルは、2024年に41.3％の最大の収益シェアを占め、市場を独占しました。これは主に、非侵襲的で、簡単で、便利な収集プロセスであるため、職場と臨床の両方の環境に適していることによる。
• 口腔液サンプルは、採取の容易さ、プライバシーの懸念の少なさ、サンプル混入のリスクの低さによって、予測期間中に大幅なCAGRで成長する見込みです。
• 2024年には、薬物治療が市場をリードし、最大の収益シェアを占めました。病院は、2025年から2030年にかけて最も速いCAGR 5.2％で成長する見込みです。
• 2024年、北米が世界の薬物スクリーニング市場で最大の収益シェアを占め、薬物乱用率の上昇、厳格な職場安全規制、薬物関連問題の統制を目的とした政府イニシアチブの増加によって牽引されました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の薬物スクリーニング市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 世界薬物スクリーニング市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 世界の薬物スクリーニング市場：製品タイプのビジネス分析

• 製品タイプセグメントダッシュボード
• 薬物スクリーニング市場：製品タイプの変動分析
• 世界の薬物スクリーニング市場規模と動向分析（製品タイプ別、2018～2030年）
• 機器
• 迅速検査装置
• 消耗品
• サービスとその他

第5章 世界の薬物スクリーニング市場：サンプルタイプのビジネス分析

• サンプルタイプセグメントダッシュボード
• 薬物スクリーニング市場：サンプルタイプの変動分析
• 世界の薬物スクリーニング市場規模と動向分析（サンプルタイプ別、2018～2030年）
• 尿サンプル
• 呼気サンプル
• 口腔液サンプル
• 毛髪サンプル
• その他のサンプル

第6章 世界の薬物スクリーニング市場：最終用途のビジネス分析

• 最終用途セグメントダッシュボード
• 薬物スクリーニング市場：最終用途の変動分析
• 世界の薬物スクリーニング市場規模と動向分析（最終用途別、2018～2030年）
• 病院
• 刑事司法および法執行機関
• 職場
• 薬物治療センター
• 個人ユーザー
• 疼痛管理センター
• 学校と大学
• その他

第7章 世界の薬物スクリーニング市場：地域の推定・動向分析

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年および2030年
• 地域別世界薬物スクリーニング市場：主なポイント
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Abbott
  • Quest Diagnostics Incorporated
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare AG
  • Laboratory Corporation of America Holdings
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • Omega Laboratories, Inc.
  • Dragerwerk AG &Co. KGaA
  • Bio-Rad Laboratories, Inc.

List of Tables

• Table 1. List Of Abbreviations
• Table 2. Global Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 3. Global Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 4. Global Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 5. Global Drug Screening Market, By Region, 2018 - 2030 (USD Million)
• Table 6. North America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
• Table 7. North America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 8. North America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 9. North America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 10. U.S. Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 11. U.S. Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 12. U.S. Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 13. Canada Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 14. Canada Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 15. Canada Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 16. Mexico Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 17. Mexico Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 18. Mexico Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 19. Europe Drug Screening Market, By Country, 2018 - 2030 (USD Million)
• Table 20. Europe Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 21. Europe Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 22. Europe Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 23. Germany Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 24. Germany Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 25. Germany Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 26. UK Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 27. UK Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 28. UK Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 29. France Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 30. France Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 31. France Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 32. Italy Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 33. Italy Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 34. Italy Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 35. Spain Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 36. Spain Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 37. Spain Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 38. Denmark Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 39. Denmark Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 40. Denmark Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 41. Sweden Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 42. Sweden Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 43. Sweden Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 44. Norway Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 45. Norway Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 46. Norway Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific Drug Screening Market, By Country, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 51. China Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 52. China Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 53. China Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 54. Japan Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 55. Japan Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 56. Japan Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 57. India Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 58. India Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 59. India Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 60. South Korea Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 61. South Korea Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 62. South Korea Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 63. Australia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 64. Australia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 65. Australia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 66. Thailand Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 67. Thailand Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 68. Thailand Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 69. Latin America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
• Table 70. Latin America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 71. Latin America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 72. Latin America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 73. Brazil Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 74. Brazil Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 75. Argentina Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 76. Argentina Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 77. Argentina Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 78. MEA Drug Screening Market, By Region, 2018 - 2030 (USD Million)
• Table 79. MEA Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 80. MEA Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 81. MEA Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 82. South Africa Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 83. South Africa Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 84. South Africa Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 85. Saudi Arabia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 86. Saudi Arabia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 88. UAE Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 89. UAE Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 90. UAE Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
• Table 91. Kuwait Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
• Table 92. Kuwait Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
• Table 93. Kuwait Drug Screening Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Sample Types
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modeling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Drug Screening Market: Market Outlook
• Fig. 10 Drug Screening Competitive Insights
• Fig. 11 Parent Market Outlook
• Fig. 12 Related/Ancillary Market Outlook
• Fig. 13 Penetration and Growth Prospect Mapping
• Fig. 14 Industry Value Chain Analysis
• Fig. 15 Drug Screening Market Driver Impact
• Fig. 16 Drug Screening Market Restraint Impact
• Fig. 17 Drug Screening Market Strategic Initiatives Analysis
• Fig. 18 Drug Screening Market: Product Type Movement Analysis
• Fig. 19 Drug Screening Market: Product Type Outlook and Key Takeaways
• Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
• Fig. 21 Rapid Testing Devices Market Estimates and Forecast, 2018 - 2030
• Fig. 22 Consumables Market Estimates and Forecast, 2018 - 2030
• Fig. 23 Services & Others Market Estimates and Forecast, 2018 - 2030
• Fig. 24 Drug Screening Market: Sample Type Movement Analysis
• Fig. 25 Drug Screening Market: Sample Type Outlook and Key Takeaways
• Fig. 26 Urine Samples Market Estimates and Forecast, 2018 - 2030
• Fig. 27 Breath Samples Market Estimates and Forecast, 2018 - 2030
• Fig. 28 Oral Fluid Samples Market Estimates and Forecast, 2018 - 2030
• Fig. 29 Hair Samples Market Estimates and Forecast, 2018 - 2030
• Fig. 30 Other Samples Market Estimates and Forecast, 2018 - 2030
• Fig. 31 Drug Screening Market: End Use Movement Analysis
• Fig. 32 Drug Screening Market: End Use Outlook and Key Takeaways
• Fig. 33 Hospitals Market Estimates and Forecasts, 2018 - 2030
• Fig. 34 Criminal Justice & Law Enforcement Agencies Market Estimates and Forecasts, 2018 - 2030
• Fig. 35 Workplaces Market Estimates and Forecasts, 2018 - 2030
• Fig. 36 Drug Treatment Centers Market Estimates and Forecasts, 2018 - 2030
• Fig. 37 Individual Users Market Estimates and Forecasts, 2018 - 2030
• Fig. 38 Pain Management Centers Market Estimates and Forecasts, 2018 - 2030
• Fig. 39 Schools & Colleges Market Estimates and Forecasts, 2018 - 2030
• Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 41 Global Drug Screening Market: Regional Movement Analysis
• Fig. 42 Global Drug Screening Market: Regional Outlook and Key Takeaways
• Fig. 43 North America Market Estimates and Forecasts, 2018 - 2030
• Fig. 44 U.S. Market Estimates and Forecasts, 2018 - 2030
• Fig. 45 Canada Market Estimates and Forecasts, 2018 - 2030
• Fig. 46 Mexico Market Estimates and Forecasts, 2018 - 2030
• Fig. 47 Europe Market Estimates and Forecasts, 2018 - 2030
• Fig. 48 UK Market Estimates and Forecasts, 2018 - 2030
• Fig. 49 Germany Market Estimates and Forecasts, 2018 - 2030
• Fig. 50 France Market Estimates and Forecasts, 2018 - 2030
• Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
• Fig. 52 Spain Market Estimates and Forecasts, 2018 - 2030
• Fig. 53 Denmark Market Estimates and Forecasts, 2018 - 2030
• Fig. 54 Sweden Market Estimates and Forecasts, 2018 - 2030
• Fig. 55 Norway Market Estimates and Forecasts, 2018 - 2030
• Fig. 56 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
• Fig. 57 China Market Estimates and Forecasts, 2018 - 2030
• Fig. 58 Japan Market Estimates and Forecasts, 2018 - 2030
• Fig. 59 India Market Estimates and Forecasts, 2018 - 2030
• Fig. 60 Thailand Market Estimates and Forecasts, 2018 - 2030
• Fig. 61 South Korea Market Estimates and Forecasts, 2018 - 2030
• Fig. 62 Australia Market Estimates and Forecasts, 2018 - 2030
• Fig. 63 Latin America Market Estimates and Forecasts, 2018 - 2030
• Fig. 64 Brazil Market Estimates and Forecasts, 2018 - 2030
• Fig. 65 Argentina Market Estimates and Forecasts, 2018 - 2030
• Fig. 66 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 67 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 68 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
• Fig. 69 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030

Drug Screening Market Growth & Trends:

The global drug screening market size is estimated to reach USD 11.99 billion by 2030 and is anticipated to expand at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and the requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Furthermore, the incidence of illegal substance uses amongst Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, launched rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring procedure, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

Drug Screening Market Report Highlights:

• Consumables held the largest revenue share of 34.5% in 2024, attributed to their essential role in rapid, accurate, and on-site testing. Furthermore, frequent product launches and the need for efficient substance detection across workplaces and healthcare settings also fuel this segment's growth
• Services and others are expected to grow at a CAGR of 4.1% over the forecast period, owing to the increasing need for specialized drug screening services, including laboratory analysis and support for compliance with regulatory standards.
• Urine samples dominated the market with the largest revenue share of 41.3% in 2024, primarily driven by their noninvasive, simple, and convenient collection process, which makes them suitable for both workplace and clinical settings.
• Oral fluid samples are expected to grow at a significant CAGR over the forecast period, driven by their ease of collection, minimal privacy concerns, and lower risk of sample adulteration.
• In 2024, drug treatment led the market and accounted for the largest revenue share. Hospitals are expected to grow at the fastest CAGR of 5.2% from 2025 to 2030.
• North America dominated the global drug screening market with the largest revenue share in 2024, driven by rising substance abuse rates, stringent workplace safety regulations, and increasing government initiatives aimed at controlling drug-related issues.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Sample Type
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Type Outlook
  • 2.2.2. Sample Type Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Drug Screening Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Global Drug Screening Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Global Drug Screening Market: Product Type Business Analysis

• 4.1. Product Type Segment Dashboard
• 4.2. Drug Screening Market: Product Type Movement Analysis
• 4.3. Global Drug Screening Market Size & Trend Analysis, By Product Type, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Immunoassays Analyzers
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Chromatography Instruments
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Breath Analyzer
    • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4.2. Fuel Cell Breath Analyzer
      • 4.4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4.3. Semi-Conductor Breath Analyzer
      • 4.4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4.4. Others Breath Analyzer
      • 4.4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Rapid Testing Devices
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Urine Testing Devices
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.2. Drug Testing Cups
      • 4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.3. Dip Cards
      • 4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2.4. Drug Testing Cassettes
      • 4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Oral Fluid Testing Devices
  • 4.5.4. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.6. Consumables
  • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Assay Kits
    • 4.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Sample Collection Devices
    • 4.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Calibrators & Controls
    • 4.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Other Consumables
    • 4.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.7. Services & Others
  • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Drug Screening Market: Sample Type Business Analysis

• 5.1. Sample Type Segment Dashboard
• 5.2. Drug Screening Market: Sample Type Movement Analysis
• 5.3. Global Drug Screening Market Size & Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
• 5.4. Urine Samples
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Breath Samples
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Oral Fluid Samples
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Hair Samples
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. Other Samples
  • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Drug Screening Market: End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Drug Screening Market: End Use Movement Analysis
• 6.3. Global Drug Screening Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Criminal Justice & Law Enforcement Agencies
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Workplaces
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Drug Treatment Centers
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Individual Users
  • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.9. Pain Management Centers
  • 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.10. Schools & Colleges
  • 6.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.11. Others
  • 6.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Drug Screening Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Global Drug Screening Market by Regional: Key Takeaways
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key Country Dynamics
    • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.1.3. Competitive Scenario
    • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Germany
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.1.3. Competitive Scenario
    • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.1.3. Competitive Scenario
    • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Thailand
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. South Africa
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.3.3. Competitive Scenario
    • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.4.3. Competitive Scenario
    • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key Company Heat Map Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Abbott
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Quest Diagnostics Incorporated
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. F. Hoffmann-La Roche Ltd
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Thermo Fisher Scientific Inc.
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Siemens Healthcare AG
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Laboratory Corporation of America Holdings
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Alfa Scientific Designs, Inc.
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. OraSure Technologies, Inc.
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Omega Laboratories, Inc.
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Dragerwerk AG & Co. KGaA
    • 8.4.10.1. Company Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. Bio-Rad Laboratories, Inc.
    • 8.4.11.1. Company Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives